Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
+1.05%
SPX
+1.03%
IXIC
+1.20%
FTSE
+0.30%
N225
+0.50%
AXJO
-0.27%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Overview

Loading chart...

Key Stats

Market Cap
543.48M
Dividend Yield
0.00%
P/E Ratio
-2.99
EPS
-2.03
Revenue
53.88M
Avg. Volume
1.13M

About

What does KURA do?
Kura Oncology, headquartered in San Diego, focuses on developing precision medicines for cancer treatment, including small molecule candidates Ziftomenib, Tipifarnib, and KO-2806. The company went public in November 2015 and employs 142 staff.
Sector
💻 Health Care
IPO
CEO
Employees
Headquarters
California, USA
Website
http://www.kuraoncology.com
Stocks
Health Care
kura
Kura Oncology
KURA
+0.16 (+2.44%)
6.73
USD
At close at Jun 06, 20:41 UTC
Summary
News
Signals
Benchmarks
Financials

Recently from Cashu

publisher logo
Cashu

Kura Oncology Partners with Peanuts for Exciting Limited-Time Sushi Promotion

about 1 month ago
publisher logo
Cashu

Kura Oncology Partners with Peanuts for Unique Dining Promotion at Kura Sushi

about 1 month ago